A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment-Reference-Cited by-同舟云学术

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment

Published:1990 Issue:2 Volume:5 Page:100-108
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Crossman A. R.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference61 articles.

1. Aromatic Amino Acids and Modification of Parkinsonism

3. Fluctuations of disability in Parkinson's disease?clinical aspects. In: eds. Movement disorders. London: Butterworths, 1982: 96-122.

4. Problems in Parkinson's disease and other akinetic-rigid syndrome. In: eds. Movement disorders 2. London: Butterworths, 1987: 65-72.

5. Antiparkinsonian activity of a single oral dose of PHNO. In: eds. Movement disorders 2 London: Butterworths, 1987: 47-51.

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring;Clinical Parkinsonism & Related Disorders;2023

2. Metabolic Networks in Parkinson’s Disease;Contemporary Clinical Neuroscience;2023

3. Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease;Biomolecules;2022-02-01

4. Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia;The Journal of Neuroscience;2021-02-09

5. Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease;Pharmacology Biochemistry and Behavior;2020-10